Medical Journals

Membrane Type 1 Matrix Metalloproteinase (Mt1-mmp/Mmp-14) Cleaves and Releases a 22-kda Extracellular Matrix Metalloproteinase Inducer (Emmprin) Fragment from Tumor Cells.

Authors:
  • Egawa Nagayasu
  • Koshikawa Naohiko
  • Tomari Taizo
  • Nabeshima Kazuki
  • Isobe Toshiaki
  • Seiki Motoharu

From: Division of Cancer Cell Research, Institute of Medical Science, the University of Tokyo, Tokyo 108-8639, Japan.

The Journal of biological chemistry

  • Publish Date: Dec 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 49
  • Pages: 37576-85
  • Medium: Print
  • Language: English
  • Citation (JAMA): Egawa Nagayasu, Koshikawa Naohiko, Tomari Taizo, et al. Membrane Type 1 Matrix Metalloproteinase (Mt1-mmp/Mmp-14) Cleaves and Releases a 22-kda Extracellular Matrix Metalloproteinase Inducer (Emmprin) Fragment from Tumor Cells.. J. Biol. Chem. Dec 2006;281:37576-85

Abstract

Proteolytic shedding is an important step in the functional down-regulation and turnover of most membrane proteins at the cell surface. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a multifunctional glycoprotein that has two Ig-like domains in its extracellular portion and functions in cell adhesion as an inducer of matrix metalloproteinase (MMP) expression in surrounding cells. Although the shedding of EMMPRIN is reportedly because of cleavage by metalloproteinases, the responsible proteases, cleavage sites, and stimulants are not yet known. In this study, we found that human tumor HT1080 and A431 cells shed a 22-kDa EMMPRIN fragment into the culture medium. The shedding was enhanced by phorbol 12-myristate 13-acetate and inhibited by TIMP-2 but not by TIMP-1, suggesting the involvement of membrane-type MMPs (MT-MMPs). Indeed, down-regulation of the MT1-MMP expression in A431 cells using small interfering RNA inhibited the shedding. The 22-kDa fragment was purified, and the C-terminal amino acid was determined. A synthetic peptide spanning the cutting site was cleaved by MT1-MMP in vitro. The cleavage site is located in the linker region connecting the two Ig-like domains. The N-terminal Ig-like domain is important for the MMP inducing activity of EMMPRIN and for cell-cell interactions, presumably through its ability to engage in homophilic interactions, and the 22-kDa fragment retained the ability to augment MMP-2 expression in human fibroblasts. Thus, the MT1-MMP-dependent cleavage eliminates the functional N-terminal domain of EMMPRIN from the cell surface, which is expected to down-regulate its function. At the same time, the released 22-kDa fragment may mediate the expression of MMPs in tumor tissues.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Antigens, CD147, Binding Sites, COS Cells, Cell Line, Cell Line, Tumor, Cercopithecus aethiops, Humans, Matrix Metalloproteinase 14, Matrix Metalloproteinase 15, Molecular Sequence Data, Molecular Weight, Peptide Fragments, Protein Structure, Tertiary, Recombinant Proteins, Transfection


Check for Full Text / PubMed Unique Identifier (PMID): 17050542


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.